InvestorsHub Logo
icon url

couldbebetter

06/08/24 7:24 AM

#425254 RE: zmanindc #425246

Zmanindc, JVs do not work. A BP acquisition makes the most
sense for obvious reasons to include the value of tax-loss carryforwards.
As lucrative as it would be to get a new product into the US market that
product would still have to be marketed which BP can do and AMRN
cannot. China remains a wild card aswe do not know how capable
Edding will be in selling product once it has CVD designation. What
is left is Europe. In my opinion Denner either finds an acceptable deal
for AMRN to be acquired or he doesn't. Without a BP BO AMRN will
struggle. Unless Denner has some secret plan for a new EPA product
a Eurocentric acquirer may be THE only option. Novo Nordisk hit a new
52 week high yesterday giving it a market cap of over $636 billion...Amarin's
market cap b comparison is under $300 million.